BDC

92.7907.25%
JL

Judy L. Gawlik Brown

Independent Director

Ms. Judy L. Gawlik Brown, M.B.A., is Independent Director of UCB SA from 2026. Ms. Brown is Independent Director of Agilent Technologies, Inc. from May 20, 2025. Ms. Brown is Director of Infinant Health, Inc. from May 2024 representing Manna Tree Partners, to help prepare Infinant Health, Inc.’s expansion into pharma. She has a wealth of knowledge from her experience in the pharmaceutical and consumer healthcare industries. Ms. Brown held various executive roles at global biotechnology leader Amgen, as SVP of corporate affairs, responsible for strategic communications, patient advocacy, ESG strategies and implementation. She served as SVP global business solutions and finance, responsible for the global business solutions, global internal audit, tax and treasury organizations. During her tenure, she was regularly recognized as a leading finance executive by Institutional Investor, the Wall Street Journal and IR Magazine. Ms. Brown serves as Member of Advisory Board at PWP Forward Acquisition Corp. I. Ms. Brown served as Senior Vice President and Chair of the Amgen Foundation at Amgen Inc. since August 2022 and served as Senior Vice President of Corporate Affairs since 2018 until August 2022 and served as its Senior Vice President of Global Business Services & Finance from April 27, 2017 to 2018. Ms. Brown served as the Chief Financial Officer and Executive Vice President of Business Operations at Perrigo Company Public Limited Company from July 1, 2006 to February 27, 2017 and served as its Principal Accounting Officer. Before joining Amgen, Ms. Brown served as EVP of business operations and CFO at Perrigo Company, where she oversaw all financial operations as well as IT, government affairs, corporate communications, shared services, M&A and strategy for over a decade. Ms. Brown served as Vice President and Corporate Controller at Perrigo Company plc from September 2004 to July 2006 and also served as its Senior Vice President. As an employee of Ernst & Young for more than nine years in the U.S. and Germany, Ms. Brown provided audit and advisory services to U.S. and European multinational public and private companies. Prior to Perrigo, she held progressive Finance, Global Product Development and Brand Marketing leadership positions in Italy and the U. S. for Whirlpool Corporation from 1998 to August 2004. She began her career in the Chicago office of Ernst & Young and then continued as an expatriate in Germany in Audit and Mergers & Acquisitions practices. She served as Finance Director of European operations at Whirlpool Corp. with responsibility for Financial Analysis and division SEC reporting. She served at Ernst & Young from 1990 to 1998. She has been a Director of Belden Inc., since February 2008. In April 2017, Ms. Brown was appointed Senior Vice President of Global Business Solutions & Finance of Amgen Corporation, a global leader in biotechnology. She served as the site head for Amgen's corporate headquarters in Thousand Oaks, California. Ms. Brown oversaw Global Business Solutions, Internal Audit, Tax and Treasury organizations. She served as Director of Perrigo Company Limited until December 18, 2013 and Omega Pharma Invest NV from March 30, 2015 to July 22, 2016. She attended the Aresty Institute of Executive Education of the Wharton School of the University of Pennsylvania. She received her MBA from the University of Chicago and a BS in Accountancy from the University of Illinois at Urbana-Champaign. Ms. Brown is a Certified Public Accountant.

Positions